Diana Chan

🩷 𝟭𝟱 𝗣𝗼𝘀𝘁𝘀 𝗡𝗼𝘁 𝗧𝗼 𝗠𝗶𝘀𝘀 𝗙𝗿𝗼𝗺 𝗔𝗦𝗕𝗿𝗦𝟮𝟬𝟮𝟲 ASBrS2026 brought the global breast surgery community together in Seattle for five days of innovation, debate, and collaboration 🎗️🔬 From surgical techniques and AI to genomics and multidisciplinary care, the meeting highlighted the ideas and advances moving breast cancer care forward. 👇 Here are 15 posts you shouldn’t miss from the American Society of Breast Surgeons Annual Meeting 2026 oncodaily.com/not-to-miss/as… @ASBrS @SBoolbol @Ermanmd @BridgeGap1 @PerimeterMed @mmejendouglas #Oncology #OncoDaily #ASBrS2026 #OncoDailyBreast #BreastCancer

Four years ago, I invested ~$40M and got involved helping build a small publicly listed company in Canada called Perimeter Medical. Why? They were trying to build an AI enabled device to help doctors do cancer surgeries better: take a tumor out from a patient, analyze it with AI while still in the surgical theater and tell with precision if all the cancer was taken out. If yes, close the patient up. If not, go back and get all the cancer. Well, we got FDA approval today!! Our product, Claire, became the FIRST FDA-approved AI-enabled imaging device for breast cancer surgery. We also got Breakthrough Designation. Currently, ~20% of women face repeat surgeries because surgeons "didn't get it all". What’s even worse is that they typically don’t find out for 10 days after the surgery until pathology has reviewed the resected tumor. That is 10 days of waiting and worrying for patients. Claire’s real-time AI + OCT tech delivers 10x the resolution of standard X-rays, identifying suspicious tissue during a surgery so surgeons can act immediately. Claire is now a regulated tool that sits in the workflow, in real time, while a surgeon is operating. It is just the start for what this platform can do for cancer care. We will first focus on ~300,000 breast cancer surgeries per year in the U.S., and then grow into other solid tumors over time. From a systems perspective, it’s also what “real AI” looks like: invisible to the patient, indispensable to the clinician, and measured in fewer surgeries  and better treatment experience .   Congratulations to @adrianvmendes and the @perimetermed team.

Big Milestone: @PerimeterMed's Claire™ has received premarket approval (PMA) from FDA. This represents a massive leap forward in our mission to transform the standard of care for #BreastCancer patients. Read more: bit.ly/4u7S4z2 #PerimeterAI #StrongerTogether

As #BreastCancerAwarenessMonth ends, our commitment continues. We’re proud to stand with #surgeons, #patients, #researchers & #advocates—all working toward better outcomes and stronger futures. Real progress happens when we’re #StrongerTogether.

"If we're not asking what patients are experiencing, those insights get lost." - @mmejendouglas in a discussion with @BridgeGap1 Watch here! 👇 linkedin.com/posts/perimeter… #StrongerTogether #PerimeterAI #MedTech